A comparative study of atenolol/nifedipine and atenolol/diuretic in hypertension.

Pharmatherapeutica Pub Date : 1986-01-01
K G Edwards, J A Tweed, P A Saul, F W Wright
{"title":"A comparative study of atenolol/nifedipine and atenolol/diuretic in hypertension.","authors":"K G Edwards,&nbsp;J A Tweed,&nbsp;P A Saul,&nbsp;F W Wright","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A prospective, randomized, double-blind between-patient study was carried out to compare the efficacy and tolerance of atenolol with nifedipine and atenolol with diuretic. Ninety-eight hypertensive patients inadequately controlled after 1-month's treatment with 100 mg atenolol alone once daily received, in addition, either 20 mg nifedipine twice daily or 5 mg amiloride plus 50 mg hydrochlorothiazide once daily for a further 8 weeks. The results of blood pressure measurements in the lying and standing positions showed that the mean reduction in standing blood pressure from atenolol baseline was 28/12 mmHg for atenolol/diuretic and 18/13 mmHg for atenolol/nifedipine. The only significant difference between treatments in blood pressure control was in lying systolic blood pressure favouring atenolol/diuretic and a trend in favour of this combination for standing systolic blood pressure. Both regimens were reasonably well tolerated, although 19 patients withdrew during the course of the trial because of side-effects (2 on atenolol alone, 10 on atenolol/diuretic and 7 on atenolol/nifedipine).</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 10","pages":"637-41"},"PeriodicalIF":0.0000,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmatherapeutica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A prospective, randomized, double-blind between-patient study was carried out to compare the efficacy and tolerance of atenolol with nifedipine and atenolol with diuretic. Ninety-eight hypertensive patients inadequately controlled after 1-month's treatment with 100 mg atenolol alone once daily received, in addition, either 20 mg nifedipine twice daily or 5 mg amiloride plus 50 mg hydrochlorothiazide once daily for a further 8 weeks. The results of blood pressure measurements in the lying and standing positions showed that the mean reduction in standing blood pressure from atenolol baseline was 28/12 mmHg for atenolol/diuretic and 18/13 mmHg for atenolol/nifedipine. The only significant difference between treatments in blood pressure control was in lying systolic blood pressure favouring atenolol/diuretic and a trend in favour of this combination for standing systolic blood pressure. Both regimens were reasonably well tolerated, although 19 patients withdrew during the course of the trial because of side-effects (2 on atenolol alone, 10 on atenolol/diuretic and 7 on atenolol/nifedipine).

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿替洛尔/硝苯地平与阿替洛尔/利尿剂治疗高血压的比较研究。
一项前瞻性、随机、双盲的患者间研究比较了阿替洛尔与硝苯地平和阿替洛尔与利尿剂的疗效和耐受性。98例高血压患者在接受100 mg阿替洛尔治疗1个月后控制不充分,每日1次,此外,20 mg硝苯地平每日2次或5 mg阿米洛利加50 mg氢氯噻嗪每日1次,再持续8周。躺卧和站立位置的血压测量结果显示,阿替洛尔/利尿剂组的站立血压平均比阿替洛尔基线降低28/12 mmHg,阿替洛尔/硝苯地平组的站立血压平均比阿替洛尔基线降低18/13 mmHg。两种治疗方法在血压控制方面的唯一显著差异是阿替洛尔/利尿剂的收缩压倾向于阿替洛尔/利尿剂的收缩压倾向于阿替洛尔/利尿剂的联合收缩压。两种方案的耐受性都相当良好,尽管19例患者在试验过程中因副作用退出(2例单独使用阿替洛尔,10例使用阿替洛尔/利尿剂,7例使用阿替洛尔/硝苯地平)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Flupenthixol and fluvoxamine in mild to moderate depression: a comparison in general practice. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters. Effects of penbutolol on plasma atrial natriuretic peptide and antidiuretic hormone levels before and after exercise: a double-blind comparison against placebo. Absence of interaction between ramipril, a new ACE-inhibitor, and phenprocoumon, an anticoagulant agent. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1